Renaud Perreaux
About Renaud Perreaux
Renaud Perreaux is a Service Sales Director at Iba, where he has worked since 2012. He has extensive experience in the medical technology sector, particularly in proton therapy, and has contributed to the global expansion of IBA's solutions.
Current Role at IBA
Renaud Perreaux serves as the Service Sales Director at IBA, a position he has held since 2012. In this role, he is responsible for overseeing service sales operations, focusing on the company's advanced medical technologies. His leadership contributes to the strategic direction of service offerings, ensuring alignment with market needs and customer expectations.
Previous Experience at IBA
Prior to his current role, Renaud Perreaux worked at IBA as a Key Account Manager from 2007 to 2011. During this four-year tenure, he managed key client relationships and contributed to the company's growth in the medical technology sector. His experience at IBA laid the foundation for his subsequent leadership role in service sales.
Career Background in Medical Technology
Renaud Perreaux has extensive experience in the medical technology sector, particularly in proton therapy. His career includes a significant role at Safran as a Program Manager from 2003 to 2007, where he managed programs related to advanced medical technologies. This background has equipped him with a deep understanding of cancer diagnosis and treatment solutions.
Contributions to Proton Therapy Solutions
Renaud Perreaux has played a significant role in the global expansion of IBA's proton therapy solutions. His efforts have contributed to the installation of these advanced technologies across Europe, the United States, and emerging markets. His work focuses on integrating innovative solutions that enhance cancer treatment through advanced radiation therapy technologies.
Education and Expertise
Renaud Perreaux possesses expertise in integrating innovative solutions for cancer diagnosis and treatment. His knowledge in advanced radiation therapy technologies positions him as a key figure in the medical technology field, particularly in the context of proton therapy advancements.